← Indorama Ventures PCL overview

Indorama Ventures PCL vs BASF: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Indorama Ventures PCL (IVL.BK)

Q3 2026
▲3▼1

Indorama Swings to Record Profit as Supply Disruptions Lift PET, MEG Spreads

  • Record profit ends five loss quarters Indorama Ventures reported a record 5.96 billion baht net profit in Q2 2026, ending five straight loss quarters. Middle East supply disruptions lifted PET and MEG spreads, the gap between raw material costs and selling prices.

    This is the single biggest new event of the period and directly explains the rebound in IVL's stock.

  • Debt reduction ahead of target Debt fell ahead of target, with the debt-to-equity ratio at 1.56x. Lower debt reduces financial risk and gives the company more flexibility, which supports the stock price.

    This is a new financial improvement that strengthens the balance sheet and investor confidence.

  • Brokers name IVL a top pick Brokers CLSA, Yuanta, and Krungsri named IVL a top pick, citing peak PET supply passing, Super El Niño-driven polyester demand, and rebounding spreads. These factors point to better times ahead for the company.

    Analyst upgrades and positive outlooks can drive buying interest and support the stock price.

  • Downgrades and macro headwinds cap gains Morgan Stanley downgraded IVL to Underweight with a 19 baht target, citing sub-cost returns and high debt. JPMorgan and Dao also cut ratings on softening spreads and higher energy costs. High oil and Fed rate hikes create a tug-of-war.

    This provides the necessary counterweight, showing that not all news was positive and risks remain.

August 2026
▲2▼2

IVL's Q2 profit recovery met with mixed analyst views

  • Q2 profit recovery confirmed IVL swung to a 5.96bn baht net profit in Q2 2026, with EBITDA up 129% and debt cut ahead of target, confirming the recovery from five loss quarters.

    This is the actual reported result, a key positive driver for the stock.

  • Bullish factors and raised targets Bulls cited the PET supply peak passing, a 20% weekly spread rise, Super El Niño boosting polyester demand, and Thailand gaining from supply-chain shifts. CLSA raised its target to 32 baht; Yuanta kept Buy at 27.50 baht.

    These are new positive arguments and analyst actions that could support the stock.

  • JPMorgan downgrade on weaker spreads JPMorgan downgraded IVL to Neutral, cutting its target to 22 baht and 2027 estimates by 32.6% on weaker spreads, signaling concerns about future profitability.

    A new negative analyst action that could pressure the stock.

  • Dao downgrade and softening spreads Dao downgraded to Hold after a 23% rally, expecting Q3 profit to soften on falling spreads and higher energy costs. Petrochemical spreads also softened as supply returned.

    A new negative view and market condition that could weigh on the stock.

Latest
▲3▼1

IVL hits 28 baht on PET recovery, then broker downgrades to Hold

  • PET cycle recovery drives profit turnaround The PET industry is entering a recovery cycle as high-cost plants close worldwide and little new capacity is added, easing oversupply. Krungsri expects IVL to swing from a 2025 loss to profits of 6.2 billion baht in 2026, rising to 9.8 billion by 2028, lifting the shares.

    This is the core fundamental reason IVL is moving: a multi-year profit turnaround from the PET cycle.

  • Super El Niño shifts textile demand to polyester Super El Niño conditions are pressuring cotton output and pushing cotton prices higher, prompting textile producers to switch to polyester fibers. That lifts demand and capacity use for IVL's Fibers and PET products, a fresh demand driver on top of the industry recovery.

    It is a new, specific demand catalyst for IVL's products that readers have not been told before.

  • Tight supply lifts Integrated PET spread 20% Chinese refineries cut operating rates, keeping polyester-chain supply tight, and the Integrated PET spread rose 20% week-on-week. Wider spreads mean IVL earns more per ton sold, directly supporting profit expectations and the share price.

    It gives the concrete supply-and-price mechanism behind IVL's improving margins this period.

  • Dao downgrades IVL to Hold after 23% rally Dao Securities cut IVL to Hold from Buy, keeping a 28 baht target, after the shares rose 23% since August and now leave little upside. It also expects third-quarter profit to weaken from the prior quarter as PET spreads fall from a high base and energy costs rise.

    It is the main counterweight: a broker saying the recovery is already priced in and near-term profit may dip.

September 2026
▲3

IVL gains on record Q2, rising petrochemical spreads, and broker upgrades

  • Record Q2 profit and stronger balance sheet IVL reported Q2 net profit of 5,961 million baht, reversing a year-ago loss, with all four businesses contributing and PET spreads at $279/ton. Net debt fell to 226 billion baht and the debt-to-equity ratio improved to 1.56 times. This confirms the profit recovery is real and strengthens the balance sheet, supporting the shares.

    The record Q2 result is the fundamental proof behind the recovery story and directly supports the stock.

  • Petrochemical spreads rebound sharply, brokers switch into IVL Bualuang reported ethylene, propylene, HDPE and PP spreads all jumped, with PP up $164/ton, and recommended switching from refinery stocks into petrochemicals, picking IVL and PTTGC. Wider spreads mean IVL earns more per ton sold, directly lifting profit expectations and the share price.

    This is the clearest new evidence that IVL's core product margins are recovering, which is the main profit driver.

  • Earnings estimates and broker top picks raised September SET earnings estimates were revised up 0.7%, with IVL gaining 7% and petrochemicals leading at 6.2%. Krungsri then named IVL a Q4 2026 top pick and part of its energy security theme. Higher estimates and repeated broker endorsements pull money into the stock.

    Upward estimate revisions and top-pick status show analysts expect more profit and are steering buyers toward IVL.

  • High oil and Fed rate hike cut both ways Brent hit $100 and the Fed raised rates to 3.75-4.00%, pressuring growth stocks and the Thai market. But brokers still favor energy and petrochemicals, naming IVL, because high oil lifts chemical prices. The tug-of-war means rate worries cap gains while oil strength supports IVL.

    This is the main counterweight: rate hikes and expensive oil can hurt the broad market even as they help IVL's spreads.

▲3

IVL gains on record Q2, rising petrochemical spreads, and broker upgrades

  • Record Q2 profit and stronger balance sheet IVL reported Q2 net profit of 5,961 million baht, reversing a year-ago loss, with all four businesses contributing and PET spreads at $279/ton. Net debt fell to 226 billion baht and the debt-to-equity ratio improved to 1.56 times. This confirms the profit recovery is real and strengthens the balance sheet, supporting the shares.

    The record Q2 result is the fundamental proof behind the recovery story and directly supports the stock.

  • Petrochemical spreads rebound sharply, brokers switch into IVL Bualuang reported ethylene, propylene, HDPE and PP spreads all jumped, with PP up $164/ton, and recommended switching from refinery stocks into petrochemicals, picking IVL and PTTGC. Wider spreads mean IVL earns more per ton sold, directly lifting profit expectations and the share price.

    This is the clearest new evidence that IVL's core product margins are recovering, which is the main profit driver.

  • Earnings estimates and broker top picks raised September SET earnings estimates were revised up 0.7%, with IVL gaining 7% and petrochemicals leading at 6.2%. Krungsri then named IVL a Q4 2026 top pick and part of its energy security theme. Higher estimates and repeated broker endorsements pull money into the stock.

    Upward estimate revisions and top-pick status show analysts expect more profit and are steering buyers toward IVL.

  • High oil and Fed rate hike cut both ways Brent hit $100 and the Fed raised rates to 3.75-4.00%, pressuring growth stocks and the Thai market. But brokers still favor energy and petrochemicals, naming IVL, because high oil lifts chemical prices. The tug-of-war means rate worries cap gains while oil strength supports IVL.

    This is the main counterweight: rate hikes and expensive oil can hurt the broad market even as they help IVL's spreads.

▲4

IVL jumps as brokers hike targets on PET supply peak and oil-driven spread recovery

  • CLSA raises target to 32 baht, sees PET supply peak passing CLSA lifted its IVL target to 32 baht from 28 and kept Outperform, saying 2026 is the last year of new PET capacity and Q3 spreads will beat expectations. A higher target from a major broker pulls the shares up because it signals the profit recovery has room to run.

    This is the single biggest new price catalyst in the period, directly lifting IVL shares 3.5%.

  • Oil spike and Venezuela OPEC exit talk lift petrochemical spreads Middle East tension pushed Dubai crude up about 5% to $93, and reports that Venezuela may leave OPEC raised hopes of more crude supply and cheaper feedstock. Analysts say petrochemical spreads have improved and recommend switching into IVL and PTTGC, pushing the shares up.

    It explains the fresh sector-wide buying that drove IVL's 4-6% jumps on Aug 28 and the broker energy lists.

  • Yuanta keeps Buy at 27.50 baht after record Q2 Yuanta maintained Buy with a 27.50 baht fair value, noting IVL's Q2 net profit of 6 billion baht was its best in 15 quarters and EBITDA grew across all businesses. The broker expects second-half slowdown is already priced in, so the shares rose 4.4% against the market.

    It is the first broker note in the period that re-anchors the stock to the strong Q2 result and sets the tone for later upgrades.

  • Thailand seen as supply-chain winner as production shifts to ASEAN IVL executives said geopolitical conflicts and trade wars are pushing factories to Thailand and ASEAN, and Thailand's petrochemical strengths and flexible supply chains are attracting investment. More regional production supports long-term demand for IVL's chemicals and packaging, a slow-building positive for the shares.

    It adds a structural demand tailwind that supports the bull case beyond short-term spread moves.

▲2▼2

IVL's Q2 profit rebound confirmed, but analysts split on what comes next

  • Q2 profit swing ends losing streak IVL reported a Q2 2026 net profit of 5.96 billion baht, reversing a year-earlier loss, with EBITDA up 129% and net debt cut to 226 billion baht ahead of target. A real profit plus faster debt reduction makes the recovery look solid, supporting the shares.

    The actual earnings result is the core new fact that validates the recovery story.

  • JPMorgan cuts target, sees valuation stretched JPMorgan downgraded IVL to Neutral and cut its target to 22 baht, slashing its 2027 earnings estimate by 32.6% on weaker MTBE and PET spreads and higher non-operating costs. This warns the strong quarter may not repeat, capping the upside.

    It is the main new counterweight to the bullish earnings news.

  • Petrochemical spreads soften as supply returns Yuanta said polyester petrochemical spreads fell week on week, and Bualuang expects Q3 prices and spreads to ease slightly as supply comes back. Lower spreads mean less profit per tonne, so the earnings recovery may slow even if levels stay above last year.

    It explains the near-term pressure on IVL's core product margins.

  • Suntory deal adds circular PET growth IVL partnered with Suntory and Iwatani to bring commercial circular PET packaging to Thailand, producing recycled preforms equal to about 400 million bottles a year, with deliveries from 2028. It strengthens the downstream packaging business and the IVL 2.0 growth plan.

    It is a new long-term demand driver for IVL's higher-value recycled products.

July 2026
▲3▼1

IVL's Q2 profit rebound meets a major broker downgrade

  • Q2 profit recovery on Middle East supply disruptions IVL expects a strong Q2 2026 profit of 6.7 billion baht, ending five straight loss quarters, as Middle East supply disruptions lifted PET and MEG spreads sharply. Higher spreads mean IVL earns more per tonne sold, directly boosting profit and supporting the stock.

    This is the core new fundamental driver of IVL's earnings and price outlook.

  • Brokers flag IVL as a top Q2 earnings standout Several Thai brokers expect IVL to post outstanding Q2 profit growth, with one forecasting a 983% year-on-year jump, and name it a top pick. Such endorsements can draw buyers and support the share price.

    Shows broad analyst recognition of the earnings rebound, reinforcing the positive case.

  • Rotation into petrochemicals on high oil prices Bualuang Securities recommends switching from refineries and electronics into lagging petrochemicals like IVL, as Middle East tensions push oil above $87 a barrel. Fund flows into the sector can lift IVL's price even before earnings fully recover.

    Highlights a new sector rotation that directly benefits IVL's demand for its shares.

  • Morgan Stanley downgrade to Underweight, target cut to 19 baht Morgan Stanley downgraded IVL to Underweight and slashed its target to 19 baht, warning that returns on capital stay below cost of capital and debt remains very high. The stock fell 8.7% as investors worried the profit recovery may not be enough to lift the valuation.

    This is the main new counterweight that directly pressured IVL's price and challenges the recovery story.

▲3▼1

IVL's Q2 profit rebound meets a major broker downgrade

  • Q2 profit recovery on Middle East supply disruptions IVL expects a strong Q2 2026 profit of 6.7 billion baht, ending five straight loss quarters, as Middle East supply disruptions lifted PET and MEG spreads sharply. Higher spreads mean IVL earns more per tonne sold, directly boosting profit and supporting the stock.

    This is the core new fundamental driver of IVL's earnings and price outlook.

  • Brokers flag IVL as a top Q2 earnings standout Several Thai brokers expect IVL to post outstanding Q2 profit growth, with one forecasting a 983% year-on-year jump, and name it a top pick. Such endorsements can draw buyers and support the share price.

    Shows broad analyst recognition of the earnings rebound, reinforcing the positive case.

  • Rotation into petrochemicals on high oil prices Bualuang Securities recommends switching from refineries and electronics into lagging petrochemicals like IVL, as Middle East tensions push oil above $87 a barrel. Fund flows into the sector can lift IVL's price even before earnings fully recover.

    Highlights a new sector rotation that directly benefits IVL's demand for its shares.

  • Morgan Stanley downgrade to Underweight, target cut to 19 baht Morgan Stanley downgraded IVL to Underweight and slashed its target to 19 baht, warning that returns on capital stay below cost of capital and debt remains very high. The stock fell 8.7% as investors worried the profit recovery may not be enough to lift the valuation.

    This is the main new counterweight that directly pressured IVL's price and challenges the recovery story.

BASF SE (BAS.XETRA)

Q3 2026
▲3▼1

BASF's coatings sale, buyback, and growth bets drive Q3

  • Coatings sale and buyback BASF completed the €7.7bn sale of its coatings business to Carlyle, boosting profit and funding a €1bn share buyback. This returns cash to shareholders and sharpens focus on core chemicals.

    Major portfolio move that directly lifted profit and shareholder returns.

  • Strong earnings and pricing power Q2 net income surged to €4.14bn, and price hikes for MDI and TDI (key chemicals) lifted margins. This shows BASF can pass on costs and benefit from tight supply.

    Earnings surge and pricing power are core drivers of investor sentiment.

  • Growth investments and potential Evonik deal New products, partnerships, capacity expansion, and AI/medical-plastics investment support future growth. A possible renewed Evonik bid could add ~20% to EPS and cash flow, though integration risks remain.

    Growth initiatives and M&A potential are forward-looking positives.

  • Regulatory and supply risks The EU emissions overhaul could raise costs, and record-low Rhine water threatens production and supply, as BASF sources ~40% of raw materials via the river. These are real headwinds.

    Environmental and logistical risks could pressure operations and costs.

September 2026
▲4

BASF pushes growth via new products, partnerships, and a possible Evonik bid

  • New product launches and partnerships expand future revenue BASF started global registration of a new herbicide, launched a low-emission catalyst and lower-carbon paper coatings, and partnered in personal care. These moves broaden BASF's product range and open new sales channels, supporting long-term revenue growth and a higher stock price.

    These are new product and partnership announcements that can drive future sales and profits, directly answering what is moving the stock.

  • Plant modernization and technology adoption boost supply and demand BASF increased acid chlorides capacity by 30% at Ludwigshafen and saw its Durasorb LNG technology adopted across Cheniere's Corpus Christi facility. Higher capacity and wider technology use can lift sales volumes and licensing revenue, pushing the stock up.

    These events show concrete operational expansions that can increase output and revenue, key drivers for the stock.

  • Possible new Evonik takeover bid could boost earnings A report says BASF may make a new offer for Evonik after an earlier bid was rejected. Analysts estimate the deal could add about 20% to earnings per share and free cash flow through 2030, though return on investment would fall and execution risks remain.

    This is a new development on the Evonik takeover that could materially affect BASF's earnings and stock price.

  • Patent lawsuit against Apple could bring damages or royalties BASF's subsidiary Trinamix sued Apple for patent infringement over facial recognition technology used in iPhones and iPads. A successful outcome could mean damages or licensing fees, adding to BASF's profits and supporting the stock.

    This is a new legal action that could result in a financial gain for BASF, affecting its stock price.

Latest
▲4

BASF pushes growth via new products, partnerships, and a possible Evonik bid

  • New product launches and partnerships expand future revenue BASF started global registration of a new herbicide, launched a low-emission catalyst and lower-carbon paper coatings, and partnered in personal care. These moves broaden BASF's product range and open new sales channels, supporting long-term revenue growth and a higher stock price.

    These are new product and partnership announcements that can drive future sales and profits, directly answering what is moving the stock.

  • Plant modernization and technology adoption boost supply and demand BASF increased acid chlorides capacity by 30% at Ludwigshafen and saw its Durasorb LNG technology adopted across Cheniere's Corpus Christi facility. Higher capacity and wider technology use can lift sales volumes and licensing revenue, pushing the stock up.

    These events show concrete operational expansions that can increase output and revenue, key drivers for the stock.

  • Possible new Evonik takeover bid could boost earnings A report says BASF may make a new offer for Evonik after an earlier bid was rejected. Analysts estimate the deal could add about 20% to earnings per share and free cash flow through 2030, though return on investment would fall and execution risks remain.

    This is a new development on the Evonik takeover that could materially affect BASF's earnings and stock price.

  • Patent lawsuit against Apple could bring damages or royalties BASF's subsidiary Trinamix sued Apple for patent infringement over facial recognition technology used in iPhones and iPads. A successful outcome could mean damages or licensing fees, adding to BASF's profits and supporting the stock.

    This is a new legal action that could result in a financial gain for BASF, affecting its stock price.

August 2026
▲2▼1

BASF beats on profit, buys back stock, faces Rhine risk, eyes Evonik

  • Q2 profit surge and €1bn buyback BASF's Q2 net income jumped to €4.14bn, helped by a €3.5bn gain from selling its Coatings unit. It kept its upgraded 2026 profit forecast and will start a €1bn share buyback in August, part of a €4bn plan. Buybacks reduce shares outstanding, which can lift the stock price.

    This is the period's biggest positive fundamental news and directly supports the share price.

  • Polyurethane price hikes lift chemical margins BASF and rivals like Wanhua and Huntsman raised MDI and TDI prices in late July and August. BASF is the world's second-largest MDI producer. Higher selling prices for these key chemicals can boost revenue and profit margins, pushing the stock up.

    It shows a broad industry pricing upturn that directly benefits BASF's earnings.

  • Low Rhine water threatens production and supplies The Rhine fell to record-low levels, disrupting barge shipping. BASF's CEO said some product supplies can't be fully secured and the risk of production interruptions rises weekly. BASF gets about 40% of raw materials via the river, so continued drought could raise costs and cut output.

    This is a real operational risk that could hurt earnings and weigh on the stock.

  • Takeover proposal for Evonik BASF proposed buying rival Evonik, which has a €12bn enterprise value. A deal would create a €74bn-revenue European chemicals giant better able to compete with Chinese and US rivals. But talks are early and may fail; BASF shares fell nearly 2% on the news, reflecting integration and funding concerns.

    This is the period's major strategic move, with both potential long-term benefits and near-term uncertainty for BASF's stock.

▲2▼1

BASF beats on profit, buys back stock, faces Rhine risk, eyes Evonik

  • Q2 profit surge and €1bn buyback BASF's Q2 net income jumped to €4.14bn, helped by a €3.5bn gain from selling its Coatings unit. It kept its upgraded 2026 profit forecast and will start a €1bn share buyback in August, part of a €4bn plan. Buybacks reduce shares outstanding, which can lift the stock price.

    This is the period's biggest positive fundamental news and directly supports the share price.

  • Polyurethane price hikes lift chemical margins BASF and rivals like Wanhua and Huntsman raised MDI and TDI prices in late July and August. BASF is the world's second-largest MDI producer. Higher selling prices for these key chemicals can boost revenue and profit margins, pushing the stock up.

    It shows a broad industry pricing upturn that directly benefits BASF's earnings.

  • Low Rhine water threatens production and supplies The Rhine fell to record-low levels, disrupting barge shipping. BASF's CEO said some product supplies can't be fully secured and the risk of production interruptions rises weekly. BASF gets about 40% of raw materials via the river, so continued drought could raise costs and cut output.

    This is a real operational risk that could hurt earnings and weigh on the stock.

  • Takeover proposal for Evonik BASF proposed buying rival Evonik, which has a €12bn enterprise value. A deal would create a €74bn-revenue European chemicals giant better able to compete with Chinese and US rivals. But talks are early and may fail; BASF shares fell nearly 2% on the news, reflecting integration and funding concerns.

    This is the period's major strategic move, with both potential long-term benefits and near-term uncertainty for BASF's stock.

July 2026
▲3▼1

BASF sells coatings, invests in AI, faces EU emissions overhaul

  • Coatings sale completed BASF finished selling its coatings unit to Carlyle for €7.7 billion, bringing in about €5.8 billion in cash and a one-time gain that lifts reported profit and earnings per share. It keeps a 40% stake in the new company, so it still shares in future upside.

    This is the single biggest event of the period, directly boosting BASF's cash and reported earnings.

  • New bio-identical collagen launch BASF and Bota Biosciences launched a new lab-made collagen ingredient for personal care. It is a fresh product that could add sales in the higher-margin beauty ingredients market, showing BASF's push into specialty chemicals beyond basic plastics.

    A concrete new product launch that supports future revenue growth in a profitable segment.

  • AI investment in medical plastics BASF is putting $1.1 billion into AI reactor technology for medical plastics, part of a broader $2.3 billion industry push. This could make production more efficient and open new high-value markets, though the payoff will take years.

    Shows BASF investing in technology that may improve margins and competitiveness over time.

  • EU emissions trading overhaul The EU is revising its carbon permit system, which could raise costs for heavy polluters like BASF. BASF is lobbying for a slower pace, warning that strict rules risk pushing industry out of Europe. The final outcome is still uncertain, but tighter rules would weigh on profits.

    A regulatory risk that could increase BASF's operating costs and affect its European competitiveness.

▲3▼1

BASF sells coatings, invests in AI, faces EU emissions overhaul

  • Coatings sale completed BASF finished selling its coatings unit to Carlyle for €7.7 billion, bringing in about €5.8 billion in cash and a one-time gain that lifts reported profit and earnings per share. It keeps a 40% stake in the new company, so it still shares in future upside.

    This is the single biggest event of the period, directly boosting BASF's cash and reported earnings.

  • New bio-identical collagen launch BASF and Bota Biosciences launched a new lab-made collagen ingredient for personal care. It is a fresh product that could add sales in the higher-margin beauty ingredients market, showing BASF's push into specialty chemicals beyond basic plastics.

    A concrete new product launch that supports future revenue growth in a profitable segment.

  • AI investment in medical plastics BASF is putting $1.1 billion into AI reactor technology for medical plastics, part of a broader $2.3 billion industry push. This could make production more efficient and open new high-value markets, though the payoff will take years.

    Shows BASF investing in technology that may improve margins and competitiveness over time.

  • EU emissions trading overhaul The EU is revising its carbon permit system, which could raise costs for heavy polluters like BASF. BASF is lobbying for a slower pace, warning that strict rules risk pushing industry out of Europe. The final outcome is still uncertain, but tighter rules would weigh on profits.

    A regulatory risk that could increase BASF's operating costs and affect its European competitiveness.